Samsung Bioepis’ Soliris Biosimilar Heads For EMA Review

European Agency Accepts Filing For SB12 Eculizumab Candidate

 
• By David Wallace
Eculizumab mab symbol yellow background
Samsung Bioepis has had its eculizumab filing accepted by the EMA • Source: Shutterstock

More from Biosimilars

More from Products